Recently, researchers designed novel erythrocyte-cancer cell membrane-coated histidine copolymer micelles to deliver BLZ945 that holds immune camouflage capability to prolong circulation time and specifically deplete TAMs, which increases the infiltration of CD8+ cells and inhibits tumor growth [133]. The gene discussed is CD8A; the disease is neoplasm.